We’re excited to share Claudia’s recent interview with Advanced Science News,
where she discusses how our groups explores cell memory and its potential to
advance patient-specific treatments.

🔬Research Insights: Our work focuses on the extracellular matrix (ECM) and its
crucial role in disease development. By recreating the ECM using hydrogels, we are able to grow organoids—miniature models of human organs that mimic real tissues.
These models serve as platforms for more accurate drug testing and, most
importantly, enable the development of patient-specific therapies.

💡Why It Matters: The goal is to better understand how cells interact with their
surroundings, allowing us to develop therapies that are tailored to the individual.
This will help advance treatments for complex conditions like cancer and lung
diseases, making healthcare more effective and personalized.

✨Looking Ahead: We’re still just scratching the surface. We believe that by focusing on cell memory and organ modeling, we will make significant advances toward transforming healthcare and providing better outcomes for patients.

A big thank you to Advanced Science News for the opportunity to highlight our
research!
Read the full interview here:[https://www.advancedsciencenews.com/claudia-loebel-understanding-cell-memory-could-lead-to-patient-specific-treatments/]